Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
29,579,010
-
Total 13F shares
-
3,659,571
-
Share change
-
-218,503
-
Total reported value
-
$60,566,148
-
Price per share
-
$16.54
-
Number of holders
-
62
-
Value change
-
-$3,857,113
-
Number of buys
-
28
-
Number of sells
-
29
Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q1 2022
As of 31 Mar 2022,
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,659,571 shares.
The largest 10 holders included
NEEDHAM INVESTMENT MANAGEMENT LLC, MORGAN STANLEY, FLAGSHIP HARBOR ADVISORS, LLC, Advisors Asset Management, Inc., WELLS FARGO & COMPANY/MN, LPL Financial LLC, LAZARD ASSET MANAGEMENT LLC, UBS Group AG, Atlantic Union Bankshares Corp, and 180 WEALTH ADVISORS, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.